Exozirkel - The circadian rhythm of proteomic liquid biopsy markers from extracellular vesicles. - Exozirkel

Deutsches Krebsforschungszentrum Heidelberg0 个研究点目标入组 30 人开始时间: 2023年3月9日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Healthy volunteers: no further
•Cancer patients:
•- systemic tumor disease currently requiring treatment (systemic: leukemia, lymphoma (stage >I), myelodysplastic syndrome/myeloproliferative neoplasia, metastasized solid tumor)
•- scheduled inpatient stay of at least 3 days

•Healthy individuals:
•- any condition requiring medication currently or less than one month ago
•- regular intake of medication, including oral contraceptives (excluding vitamins)
•- currently or less than two months ago smoking, alcohol or substance abuse
•- anemia (hemoglobin peripheral blood, determined by patient history, <10g/dl (female) or <11g/dl (male) within the last year)
•- symptomatic hypotonia (blood pressure regularly or several times below 100/60 mmHg)
•- collapse or syncope with orthostasia several times in patient history
•Cancer patients:
•- severe anemia (hemoglobin in the last month at least once below 7g/dl, several times below 8g/dl or currently (within 72 hours before start of study) below 9g/dl
•- hypotonia (blood pressure in the last month regularly or several times below 100/60mmHg or currently 110/60mmHg)
•- collapse or syncope with orthostasia several times in patient history
•- IV line infection currently or less than one month ago
•- intake of oral contraceptives

发起方

Deutsches Krebsforschungszentrum Heidelberg